Loading...
XASX
HMD
Market cap21mUSD
Jul 10, Last price  
0.04AUD
1D
-2.50%
1Q
-11.36%
IPO
-79.47%
Name

Hera Med Ltd

Chart & Performance

D1W1MN
XASX:HMD chart
P/E
P/S
109.66
EPS
Div Yield, %
Shrs. gr., 5y
52.78%
Rev. gr., 5y
37.72%
Revenues
196k
-13.18%
000147,14139,51683,681215,808413,185225,492195,772
Net income
0k
P
000-3,166,599-3,358,969-5,708,943-4,880,663-4,502,770-3,398,2650
CFO
-2m
L-49.31%
000-2,759,733-2,779,198-3,231,788-2,560,313-5,572,373-4,814,402-2,440,659

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

HeraMED Limited and its associated entities are dedicated to the design, production, and sale of at-home fetal heart rate monitors and comprehensive pregnancy monitoring systems. These solutions are offered to consumers throughout Australia, Europe, and Israel. Key products include HeraBEAT, a device enabling expectant mothers to personally track their baby's heartbeat, and HeraCARE, a sophisticated digital platform facilitating the creation and deployment of health solutions for effective maternity care management. The company is also at the forefront of developing EchoBEAT, envisioned as the subsequent evolution of its domestic pregnancy monitoring tools, alongside Orion, an artificial intelligence-driven system engineered for profound pregnancy monitoring analysis. A strategic partnership with Mayo Clinic supports the ongoing advancement of the HeraCARE pregnancy management platform. Established in 2011, HeraMED Limited operates from its main office in Netanya, Israel.
IPO date
Dec 12, 2018
Employees
Domiciled in
IL
Incorporated in
IL

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT